Skip to main content
Signal8

Malik Rajesh

SEC insider (Form 3/4/5 filer). CIK 0001706853. Chief Medical Officer at G1 Therapeutics, Inc. (GTHX). 3 reported Form 4/5 transactions since Sep 2024; latest on Sep 18, 2024. Located in RESEARCH TRIANGLE PARK, NC.

Companies Malik Rajesh has filed insider reports for

  • G1 Therapeutics, Inc. (GTHX): Officer, Chief Medical Officer
Malik Rajesh profile photo

Malik Rajesh

CIK: 0001706853

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)1 (33.3%)

Compensation grants

Other (G, F, J, C, D, …)2 (66.7%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

G1 Therapeutics, Inc. logo
GTHX

G1 Therapeutics, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (3 total)

  • G1 Therapeutics, Inc. logo
    GTHX

    G1 Therapeutics, Inc.

    Sep 18, 2024
    Award
    Direct
    17.9K shares-
  • G1 Therapeutics, Inc. logo
    GTHX

    G1 Therapeutics, Inc.

    Sep 18, 2024
    Disposition
    Direct
    89.8K shares-
  • G1 Therapeutics, Inc. logo
    GTHX

    G1 Therapeutics, Inc.

    Sep 18, 2024
    Tender Offer
    Direct
    87.5K shares-

1-3 of 3